DHA与肺部疾病的研究进展
作者: |
1尹晓阳,
2胡瑞成
1 南华大学附属省马王堆医院呼吸内科,长沙 410016 2 湖南省人民医院呼吸内科,长沙 410016 |
通讯: |
胡瑞成
Email: huruicheng@hotmail.com |
DOI: | 10.3978/j.issn.2095-6959.2017.05.036 |
基金: | 国家自然科学基金, 81070035 |
摘要
二十二碳六烯酸(docosahexaenoic acid,DHA)是n-3多不饱和脂肪酸(n-3 polyunsaturated fatty acids,n-3 PUFAs)中的一员。早期研究表明DHA可以预防心血管疾病,并可以改善大脑功能。最近研究表明DHA具有抗炎、抗氧化、抗癌等作用。近年来有关DHA和肺部疾病相关性受到研究者的关注。
关键词:
二十二碳六烯酸
肺癌
慢性阻塞性肺疾病
哮喘
Research progress in DHA and lung disease
CorrespondingAuthor: HU Ruicheng Email: huruicheng@hotmail.com
DOI: 10.3978/j.issn.2095-6959.2017.05.036
Abstract
Docosahexaenoic acid (DHA) is a member of n-3 polyunsaturated fatty acids (n-3 PUFAs). Previous research indicated that DHA has the effect of preventing and treating angiocardiopathy, as well as improving the function of the brain. However, recent studies have shown that DHA has the role on anti-inflammatory, anti-oxidation and anticancer. Recently, more and more attention has been paid to the relationship between DHA and lung diseases.